To view this email as a web page, click here

   Home

Subscribe

Advertise

 

 

 

 

March 13, 2019

Today's Rundown

Featured Story

Karuna hires another ex-Lilly scientist in quest to resurrect Alzheimer’s drug

Christian Felder has joined Karuna Pharmaceuticals as VP of discovery research. The appointment reunites Felder with xanomeline, a once-failed Alzheimer’s disease drug he helped through early development while at Eli Lilly.

Top Stories

BioNTech lines up $800M Nasdaq IPO to fuel mRNA R&D: Reuters

BioNTech is lining up a Nasdaq IPO that could raise $800 million, according to Reuters. The German mRNA specialist is reportedly planning to fuel its cash-intensive plans by following rival Moderna on to public markets.

With NCI Director Sharpless in as interim FDA head, what does that mean for interagency cooperation?

The announcement that NCI Director Ned Sharpless will take on the role of acting commissioner of the FDA has raised some intriguing speculation about the possibilities for interagency cooperation between the federal government’s main medical research and innovation arm and its industry regulator.

[Sponsored] Incorporating The Patient Voice To Improve Ulcerative Colitis Recruitment

Strengthen Your Protocol With Patient Insights. See how Covance helps sponsors reduce patient burden to increase participation and improve patient retention.

Akebia’s Japanese vadadustat data ‘bode well’ for larger trials: analysts

Though the Japanese data aren’t a perfect predictor of what might happen in vadadustat’s global registrational studies, Piper Jaffray analysts called them “a nice proxy” for those trials, which are expected to read out in 2020.

Deerfield ponies up $100M for translational research deal with Harvard

Deerfield Management and Harvard University are setting up a new company dubbed Lab1636, with $100 million in backing from Deerfield. In addition to funding research on campus, Lab1636 will support R&D projects, which could include helping teams validate targets or out-license their work to other companies.

Resources

[Whitepaper] The Right Partner Can Improve Flexibility and Mitigate Risks from Forecast Inaccuracy in Biomanufacturing

The Right Partner Can Improve Flexibility and Mitigate Risks from Forecast Inaccuracy in Biomanufacturing.

[Whitepaper] How changes in drug substance processes can affect formulation

Download this whitepaper to learn more.

[Research] Maximize Pharma Marketing ROI with Digital HCP Engagement

Which HCP Touchpoints and channels are yielding the best results in today’s digital world?

[Whitepaper] Cell-Based Cancer Immunotherapies: Commercial Risk, Curative Reward

White paper outlining the key types of cell-based immunotherapies in oncology, as well as the development and commercial outlook for each.

[Whitepaper] Better Market Intelligence With Smart Search

It’s never been more challenging to stay on top of trends and innovation shaping the future of healthcare. Discover how AI can help competitive intelligence teams achieve more proactive strategies.

[Whitepaper] Accelerate Time To Market Working With Industry Specialist MSP

With FDA approval imminent, start-up Life Sciences company partners with an industry focused MSP to design and manage its regulated cloud-based infrastructure to speed time to market.

[Survey] Veeva 2019 Unified Clinical Operations Survey

Share your thoughts on the life sciences industry's progress in improving study execution.

[eBook] 2018 Weekly Compendium

The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry.

Events